Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.02
-0.01 (-0.10%)
Feb 28, 2025, 11:52 AM EST - Market open
TDAC Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 0.55 | 0.49 | 0.07 |
| Operating Expenses | 0.55 | 0.49 | 0.07 |
| Operating Income | -0.55 | -0.49 | -0.07 |
| Pretax Income | -0.55 | -0.49 | -0.07 |
| Net Income | -0.55 | -0.49 | -0.07 |
| Net Income to Common | -0.55 | -0.49 | -0.07 |
| Shares Outstanding (Basic) | 4 | 4 | 4 |
| Shares Outstanding (Diluted) | 4 | 4 | 4 |
| EPS (Basic) | -0.14 | -0.12 | -0.02 |
| EPS (Diluted) | -0.14 | -0.12 | -0.02 |
| Free Cash Flow | -0.04 | -0 | -0.15 |
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.04 |
| EBIT | -0.55 | -0.49 | -0.07 |
Source: S&P Capital IQ. Standard template.
Financial Sources.